Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022

Business Wire January 10, 2022

AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Business Wire December 20, 2021

AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference

Business Wire November 12, 2021

AtriCure Reports Third Quarter 2021 Financial Results

Business Wire November 3, 2021

AtriCure to Participate in Upcoming Investor Conferences

Business Wire October 26, 2021

AtriCure to Announce Third Quarter 2021 Financial Results

Business Wire October 5, 2021

AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

Business Wire August 31, 2021

AtriCure Announces U.S. Launch of the AtriClip® PRO•V™ Device

Business Wire September 12, 2017

AtriCure to Present at the Morgan Stanley Global Healthcare Conference

Business Wire August 18, 2017

AtriCure Reports Second Quarter 2017 Financial Results

Business Wire July 27, 2017

Investor Network: AtriCure, Inc. to Host Earnings Call

Accesswire July 27, 2017

AtriCure to Present at the Canaccord Genuity 37th Annual Growth Conference

Business Wire July 20, 2017

AtriCure Announces Hiring of Chief Technology Officer

Business Wire July 18, 2017

AtriCure to Announce Second Quarter 2017 Financial Results

Business Wire July 6, 2017

AtriCure to Present at the JMP Securities Life Science Conference

Business Wire May 18, 2017

AtriCure Reports First Quarter 2017 Financial Results

Business Wire May 4, 2017

AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide

Business Wire April 25, 2017

AtriCure to Announce First Quarter 2017 Financial Results

Business Wire April 7, 2017

AtriCure Names Two New Members to its Board of Directors

Business Wire March 21, 2017

AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical Trial

Business Wire March 14, 2017